MELETIUS LTD
Company number 13106536 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
MELETIUS LTD - Analysis Report
Company Number: 13106536
Analysis Date: 2025-07-20 11:42 UTC
Financial Health Assessment for MELETIUS LTD
1. Financial Health Score: Grade D
Explanation:
MELETIUS LTD exhibits significant financial distress symptoms, including sharply negative net assets and large working capital deficits. While the company remains active and operational, the financial “vital signs” reveal a fragile condition that requires urgent remedial action to avoid further deterioration or potential insolvency risks.
2. Key Vital Signs and Interpretation
| Metric | 2023 Value (£) | Interpretation |
|---|---|---|
| Fixed Assets | 421,860 | Asset base has grown substantially, indicating investment in property/equipment. |
| Current Assets | 75,116 | Current assets are modest but insufficient to cover short-term liabilities. |
| Cash | 7,077 | Low cash reserves, indicating limited liquid buffer for day-to-day operations. |
| Debtors | 39,959 | Moderate receivables but may face collection risks given liquidity constraints. |
| Current Liabilities | 2,169,415 | Very high current liabilities creating severe short-term financial pressure. |
| Net Current Assets (Working Capital) | -2,094,299 | Strong symptom of liquidity distress; current liabilities exceed current assets by a large margin. |
| Net Assets (Shareholders' Funds) | -1,672,439 | Negative net worth indicates cumulative losses and insolvency on a balance sheet basis. |
| Share Capital | 100 | Minimal share capital, showing limited equity cushion. |
| Employee Count | 23 (2023) | Workforce increased from 12 in prior year, implying rising operational scale or costs. |
Interpretation:
- The company’s working capital deficit is the most alarming vital sign, akin to a patient with dangerously low blood pressure: the business lacks the liquid resources to meet immediate obligations.
- Negative net assets signal accumulated losses eroding shareholder equity, similar to a chronic illness weakening the company’s financial "immune system."
- The rise in fixed assets and workforce suggests ongoing investment and growth ambitions but potentially overextending financial capacity without sufficient cash flow support.
- Low cash and increasing trade creditors widen the liquidity gap, a symptom of distress that requires urgent management attention.
3. Diagnosis: Financial Condition Assessment
MELETIUS LTD is in a financially compromised state, characterized by:
- Severe liquidity constraints: The company’s current liabilities dwarf current assets, indicating a critical shortfall in short-term financial resources. This is a clear symptom of acute financial stress, risking inability to pay suppliers or meet payroll without new financing or restructuring.
- Negative equity position: The balance sheet reflects cumulative losses, akin to a patient with a chronic condition untreated over time. Without intervention, this could lead to insolvency or forced restructuring.
- Growth vs. financial strain: The company has invested heavily in tangible assets and increased staff, which may be beneficial long-term but currently exacerbates cash flow pressures. This indicates a mismatch between operational scale and financial stability.
- No audit exemption and compliance: The company complies with filing obligations and maintains active status, indicating management awareness and regulatory compliance, a positive sign amidst financial difficulties.
Underlying causes could include:
- Insufficient revenue or profit margins to cover operational and capital expenses.
- Over-reliance on short-term credit facilities or delayed customer payments.
- Possibly aggressive expansion or capital expenditure financed by debt rather than equity.
4. Recommendations: Actions to Improve Financial Wellness
Urgent Cash Flow Management:
- Conduct a detailed cash flow forecast to identify imminent liquidity gaps.
- Negotiate extended payment terms with creditors to ease short-term pressure.
- Accelerate debtor collections through incentives or tightening credit control.
Capital Restructuring:
- Explore equity injection from current shareholders or new investors to restore net asset positivity.
- Consider restructuring existing liabilities to convert short-term debt into longer-term facilities.
Operational Efficiency Review:
- Analyze cost structure, especially relating to increased workforce and asset base, to identify potential savings.
- Pause or scale back capital expenditures until liquidity improves.
Profitability Focus:
- Review pricing strategies and product mix to enhance margins.
- Increase sales efforts focusing on cash-generative contracts.
Regular Financial Monitoring:
- Implement monthly financial health “check-ups” focusing on liquidity ratios and working capital metrics.
- Engage with financial advisors or turnaround specialists for strategic guidance.
Medical Analogy Summary:
MELETIUS LTD’s financial condition resembles a patient with severe dehydration and organ strain—large liabilities overwhelm the liquid assets (cash), the heart of the business’s financial health. Without prompt fluid (cash) replenishment and treatment (cost control and capital restructure), the prognosis worsens. However, the company’s active status and ongoing investments indicate potential for recovery if managed aggressively.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.